LBA9 Innovatv 301/Engot-Cx12/gog-3057: A Global, Randomized, Open-Label, Phase III Study of Tisotumab Vedotin Vs Investigator’s Choice of Chemotherapy in 2L or 3L Recurrent or Metastatic Cervical Cancer
Annals of Oncology(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined